Peter A. Jones
机构: Chief Scientific Officer, Van Andel Institute
每年引用次数
引用次数
引用: 114,837
H-指数: 148
I10-指数 : 379
出版物: 520
Wilson HJ, Osborne J: Impact properties of dental materials.
P A Jone
British Dental Journal 129 ( 12) 565 -570
13
1970
Immunological abnormalities in iron deficiency anaemia.
Jacobs A , Jones P , Bentley Dp , Joynson D
British Journal of Haematology 25 ( 2) 283
1973
Ferritinaemia in Leukaemia and Hodgkin's Disease
P A E Jones , F M Miller , M Worwood , A Jacobs
British Journal of Cancer 27 ( 3) 212 -217
125
1973
Coordinate regulation of Igf-2 and H19 in cultured cells
Ferguson-Smith Ac , Jones Pa , Surani Ma , Eversole-Cire P
Cell Growth & Differentiation 6 ( 3) 337 -345
20
1995
5-Methylcytosine as an endogenous mutagen in the p53 tumor suppressor gene.
WM Rideout 3rd , GA Coetzee , AF Olumi , CH Spruck
Princess Takamatsu symposia 22 207 -219
10
1991
Molecular analysis of human bladder cancer.
AF Olumi , EC Skinner , YC Tsai , PA Jones
Seminars in urology 8 ( 4) 270
17
1990
Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms.
Jones Pa , Droller Mj
Seminars in urology 11 ( 4) 177 -192
61
1993
Degradation of artificial tissue substrates.
DeClerck Ya , Laug We , Jones Pa , Isaacs H
Symposium on Fundamental Cancer Research 36 177 -185
1
1983
Possible mechanisms for differentiating between proteins destined for internal use and export in mammalian cells.
Hawtrey Ao , Jones Pa , Scott-Burden T
The South African journal of medical sciences 35 ( 3) 81 -84
1
1970
DNA methylation and drug resistance in variants of C3H10T1/2 C1 8 cells.
Jones Pa , Michalowsky La
Progress in Clinical and Biological Research 226 391
1
1986
Extracellular matrix destruction by invasive tumor cells
Pater A. Jones , Yves A. De Clerck
Cancer and Metastasis Reviews 1 ( 4) 289 -317
107
1982
Bladder cancer epidemiology and pathogenesis.
P A Jones , R K Ross , M C Yu
Seminars in Oncology 23 ( 5) 536 -545
83
1996
p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
D Esrig , S Groshen , S C Chen , P W Nichols
American Journal of Pathology 143 ( 5) 1389 -1397
538
1993
DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.
T L Kautiainen , P A Jones
Journal of Biological Chemistry 261 ( 4) 1594 -1598
157
1986
Inhibition of chemically inducced morphological transformation and reversion of the transformed phenotype by ascorbic acid. Abstr.
P A Jones , W F Benedict
80
1980
Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
C H Spruck , J M Van Tornout , P W Nichols , M C Yu
Cancer Epidemiology, Biomarkers & Prevention 6 ( 7) 493 -497
18
1997
Progressive stages of "transdifferentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2'-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT.
P Boukamp , J Chen , F Gonzales , P A Jones
Journal of Cell Biology 116 ( 5) 1257 -1271
25
1992
DNA methylation in blood from neonatal screening cards and the association with BMI and insulin sensitivity in early childhood.
S J van Dijk , T J Peters , M Buckley , J Zhou
International Journal of Obesity 42 ( 1) 28 -35
30
2018
Studies on the Binding and Distribution of Radioactively Labelled 3′-Methylcholanthrene in Subcellular Fractions of Rat Liver
P A Jones , A O Hawtrey
British Journal of Cancer 25 ( 4) 845 -852
4
1971
Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene.
H Sasaki , P A Jones , J R Chaillet , A C Ferguson-Smith
Genes & Development 6 ( 10) 1843 -1856
240
1992